Related Experiment Video

Updated: May 18, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

Molecular mechanisms of melatonin's inhibitory actions on breast cancers

Sara Proietti1, Alessandra Cucina, Russel J Reiter

  • 1Department of Clinical and Molecular Medicine, University La Sapienza, Rome, Italy.

Cellular and Molecular Life Sciences : CMLS
|September 26, 2012
PubMed

Insights

Melatonin, a hormone, demonstrates significant anticancer effects by inhibiting tumor growth and promoting cell death. Its potential in treating hormone-dependent cancers, like breast cancer, is supported by various mechanisms.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • Melatonin is a hormone with diverse physiological roles.
  • It is implicated in various pathological processes, including cancer development.
  • Previous research suggests melatonin possesses anticancer properties.

Purpose of the Study:

  • To investigate the anticancer effects of melatonin.
  • To explore melatonin's role in inhibiting the growth of hormone-dependent human tumors.
  • To examine melatonin's efficacy in breast cancer models.

Main Methods:

  • In vivo studies using chemically induced rat mammary tumor models.
  • In vitro studies utilizing human breast cancer cell lines.
  • Analysis of melatonin's impact on cancer cell proliferation, apoptosis, and differentiation.

Main Results:

  • Melatonin reduced the incidence of experimentally induced cancers.
  • Significant inhibition of growth was observed in certain human tumors, particularly hormone-dependent cancers.
  • Anticancer effects were confirmed in both in vivo and in vitro breast cancer studies.

Conclusions:

  • Melatonin exhibits potent antitumoral properties.
  • Its mechanisms of action include apoptosis activation, proliferation inhibition, and promotion of cell differentiation.
  • Melatonin shows promise as a therapeutic agent for hormone-dependent cancers, including breast cancer.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice06:42

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice

Published on: April 16, 2018

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...